Eric Stefanich

2.9k total citations
44 papers, 1.8k citations indexed

About

Eric Stefanich is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Eric Stefanich has authored 44 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 19 papers in Immunology and 16 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Eric Stefanich's work include Monoclonal and Polyclonal Antibodies Research (16 papers), Receptor Mechanisms and Signaling (9 papers) and CAR-T cell therapy research (8 papers). Eric Stefanich is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (16 papers), Receptor Mechanisms and Signaling (9 papers) and CAR-T cell therapy research (8 papers). Eric Stefanich collaborates with scholars based in United States, Poland and France. Eric Stefanich's co-authors include Paul J. Fielder, R.L. Whiting, Richard M. Eglen, Anton D. Michel, Melinda Marian, Karen Carver-Moore, Erik H.F. Wong, Douglas W. Bonhaus, Jeff Lutman and Gilbert-André Keller and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Eric Stefanich

42 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eric Stefanich United States	23	804	467	410	397	350	44	1.8k
Anika Agarwal United States	21	965 1.2×	565 1.2×	164 0.4×	270 0.7×	286 0.8×	26	2.3k
Michael Leserer Germany	4	1.2k 1.5×	117 0.3×	186 0.5×	176 0.4×	280 0.8×	4	1.9k
Eric D. Tomhave United States	18	1.1k 1.4×	101 0.2×	363 0.9×	749 1.9×	265 0.8×	19	2.1k
Elizabeth J. Quackenbush United States	25	2.1k 2.6×	387 0.8×	226 0.6×	1.4k 3.6×	199 0.6×	45	3.8k
William Fieles United States	10	612 0.8×	324 0.7×	222 0.5×	149 0.4×	115 0.3×	13	1.1k
Johannes Schlöndorff United States	23	1.8k 2.2×	128 0.3×	105 0.3×	304 0.8×	227 0.6×	39	3.2k
Karen L. Philpott United Kingdom	19	1.3k 1.7×	97 0.2×	92 0.2×	516 1.3×	378 1.1×	23	2.3k
Christian Maasch Germany	23	1.1k 1.3×	192 0.4×	61 0.1×	321 0.8×	76 0.2×	30	1.9k
Christopher J. Molineaux United States	21	1.5k 1.8×	635 1.4×	53 0.1×	216 0.5×	645 1.8×	40	2.3k
Michelle M. Williams United States	21	799 1.0×	168 0.4×	156 0.4×	213 0.5×	41 0.1×	41	1.5k

Countries citing papers authored by Eric Stefanich

Since Specialization

Citations

This map shows the geographic impact of Eric Stefanich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Stefanich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Stefanich more than expected).

Fields of papers citing papers by Eric Stefanich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Stefanich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Stefanich. The network helps show where Eric Stefanich may publish in the future.

Co-authorship network of co-authors of Eric Stefanich

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Stefanich. A scholar is included among the top collaborators of Eric Stefanich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Stefanich. Eric Stefanich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Ran, et al.. (2025). Cellular Kinetics and Biodistribution of Adoptive T Cell Therapies: from Biological Principles to Effects on Patient Outcomes. The AAPS Journal. 27(2). 55–55. 1 indexed citations

Tao, Xun, Siddharth Sukumaran, Gizette Sperinde, et al.. (2024). Sialic Acid Mediated Endothelial and Hepatic Uptake: A Mechanism based Mathematic Model Elucidating the Complex Pharmacokinetics and Pharmacodynamics of Efmarodocokin Alfa, a Variably Glycosylated Fusion Protein. Journal of Pharmaceutical Sciences. 113(7). 1975–1986. 1 indexed citations

Cai, Hao, Xun Tao, Jeongsup Shim, et al.. (2023). Mini-PBPK-Based Population Model and Covariate Analysis to Assess the Complex Pharmacokinetics and Pharmacodynamics of RO7449135, an Anti-KLK5/KLK7 Bispecific Antibody in Cynomolgus Monkeys. The AAPS Journal. 25(4). 64–64. 5 indexed citations

Yadav, Rajbharan, Siddharth Sukumaran, Tanja S. Zabka, et al.. (2022). Nonclinical Pharmacokinetics and Pharmacodynamics Characterization of Anti-CD79b/CD3 T Cell-Dependent Bispecific Antibody Using a Surrogate Molecule: A Potential Therapeutic Agent for B Cell Malignancies. Pharmaceutics. 14(5). 970–970. 5 indexed citations

Cohen, Sivan, Shan Chung, Christoph Spiess, et al.. (2021). An integrated approach for characterizing immunogenic responses toward a bispecific antibody. mAbs. 13(1). 1944017–1944017. 16 indexed citations

Tang, Meina, Mary Keir, Rich Erickson, et al.. (2018). Review article: nonclinical and clinical pharmacology, pharmacokinetics and pharmacodynamics of etrolizumab, an anti‐β7 integrin therapy for inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 47(11). 1440–1452. 26 indexed citations

Rothenberg, Michael E., Yehong Wang, Annemarie Lekkerkerker, et al.. (2018). Randomized Phase I Healthy Volunteer Study of UTTR1147A (IL‐22Fc): A Potential Therapy for Epithelial Injury. Clinical Pharmacology & Therapeutics. 105(1). 177–189. 53 indexed citations

Stefanich, Eric, Julie Rae, Siddharth Sukumaran, et al.. (2018). Pre-clinical and translational pharmacology of a human interleukin-22 IgG fusion protein for potential treatment of infectious or inflammatory diseases. Biochemical Pharmacology. 152. 224–235. 41 indexed citations

Lekkerkerker, Annemarie, Brandon Harder, Prasad S. Kulkarni, et al.. (2017). P418 Pharmacodynamic biomarkers demonstrate dose-dependent pharmacological activity of the IL-22Fc fusion protein UTR1147A in healthy volunteers in a phase 1a clinical trial. Journal of Crohn s and Colitis. 11(suppl_1). S289–S289. 3 indexed citations

10.

Chen, Xiaocheng, Yvonne Chen, Mark S. Dennis, et al.. (2014). Pre-Clinical Characterization of T Cell-Dependent Bispecific Antibody Anti-CD79b/CD3 As a Potential Therapy for B Cell Malignancies. Blood. 124(21). 4507–4507. 3 indexed citations

11.

Yu, Marcella, Darren L. Brown, Chae Reed, et al.. (2012). Production, characterization and pharmacokinetic properties of antibodies with N-linked Mannose-5 glycans. mAbs. 4(4). 475–487. 162 indexed citations

12.

Scheerens, Heleen, Zheng Su, Bryan Irving, et al.. (2011). MTRX1011A, a humanized anti-CD4 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a Phase I randomized, double-blind, placebo-controlled study incorporating pharmacodynamic biomarker assessments. Arthritis Research & Therapy. 13(5). R177–R177. 17 indexed citations

13.

Stefanich, Eric, et al.. (2008). Evidence for an Asialoglycoprotein Receptor on Nonparenchymal Cells for O-Linked Glycoproteins. Journal of Pharmacology and Experimental Therapeutics. 327(2). 308–315. 23 indexed citations

14.

Coffey, Greg, Eric Stefanich, Susan L. Palmieri, et al.. (2004). In Vitro Internalization, Intracellular Transport, and Clearance of an Anti-CD11a Antibody (Raptiva) by Human T-Cells. Journal of Pharmacology and Experimental Therapeutics. 310(3). 896–904. 41 indexed citations

15.

Luoh, Shiuh-Ming, Eric Stefanich, Gregg P. Solar, et al.. (2000). Role of the Distal Half of the c-Mpl Intracellular Domain in Control of Platelet Production by Thrombopoietin In Vivo. Molecular and Cellular Biology. 20(2). 507–515. 46 indexed citations

16.

Watson, N., Helen Reddy, Eric Stefanich, & Richard M. Eglen. (1995). Characterization of the interaction of zamifenacin at muscarinic receptors in vitro. European Journal of Pharmacology. 285(2). 135–142. 19 indexed citations

17.

Tsou, Ann‐Ping, Alan Kosaka, Chinh Bach, et al.. (1994). Cloning and Expression of a 5‐Hydroxytryptamine₇ Receptor Positively Coupled to Adenylyl Cyclase. Journal of Neurochemistry. 63(2). 456–464. 159 indexed citations

18.

Wong, Erik H.F., et al.. (1993). Labelling of 5‐Hydroxytryptamine₃ Receptors with a Novel 5‐HT₃ Receptor Ligand, [³H]RS‐42358–197. Journal of Neurochemistry. 60(3). 921–930. 28 indexed citations

19.

Michel, Anton D., Eric Stefanich, & R.L. Whiting. (1989). Direct labeling of rat M3-muscarinic receptors by [3H]4DAMP. European Journal of Pharmacology. 166(3). 459–466. 107 indexed citations

20.

Michel, Anton D., Eric Stefanich, & R.L. Whiting. (1989). PC12 phaeochromocytoma cells contain an atypical muscarinic receptor binding site. British Journal of Pharmacology. 97(3). 914–920. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact